YMRC
PRTA icon

Yorktown Management & Research Company’s Prothena Corp PRTA Stock Holding History

Yorktown Management & Research Company’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,400
Closed -$398K – 501
2014
Q1 		$398K Hold
10,400
– – 0.08% 131
2013
Q4 		$276K Buy
+10,400
New +$261K 0.06% 240

Other funds holding PRTA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Yorktown Management & Research Company's PRTA Position: Q2 2014 in Review

Yorktown Management & Research Company sold out of Prothena Corp (PRTA) in Q2 2014, closing a stake of 10,400 shares — an estimated $398K sold.

Yorktown Management & Research Company first reported a position in PRTA in Q4 2013 and held it in 2 quarters. The position peaked at $398K in Q1 2014. 132 funds tracked by Wall St. Rank hold PRTA as of Q2 2014.

  • Yorktown Management & Research Company reported no remaining Prothena Corp position as of Q2 2014 after selling out during the quarter.
  • Yorktown Management & Research Company sold 10,400 Prothena Corp shares in Q2 2014, an estimated $398K.
  • Yorktown Management & Research Company first reported a position in Prothena Corp in Q4 2013 and held it in 2 quarters.
  • Yorktown Management & Research Company's Prothena Corp position peaked at $398K in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2014.

Based on Yorktown Management & Research Company's 13F filing for Q2 2014, filed 23 Jul 2014.